Skip to main content
Caplight Logo









Concinnity Genetics

Concinnity Genetics

Private
GlasgowHealthcare & Life Scienceshttps://www.concinnitygenetics.com/

Last Round

Seed

Dec 16, 2024

Total Funding Raised

$3.79M

Company Overview

Concinnity Genetics is a biotechnology company that develops AI-driven RNA design platforms to build gene control systems for gene and cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

gene therapyRNA control systemssynthetic biologygene regulationcomputational biologybiotechmRNA therapeuticsgene editingdrug discoveryprecision medicineAI-driven designtherapeutic safetygene switchesbio-designCGT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Concinnity Genetics Comparables

Compare Concinnity Genetics with similar companies based on industry and business-model similarity.

Concinnity Genetics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chromatin Bioscience
86%
SynGenSys
85%
aceRNA Technologies Co., Ltd.
83%

Concinnity Genetics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 16, 2024

Key People

Founding team and executive leadership

Jessica Birt

CEO

Executive Team

Pri Hancock

Chief Financial Officer

Executive Team

Gillian Hill

Chief Operating Officer

Executive Team

Concinnity Genetics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors grew 190% MoM, from 249 to 722.

Concinnity Genetics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Concinnity Genetics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Concinnity Genetics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow
Employee Range10
Year Founded2023
Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?